Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23928464 | 0.96 | EPHX2 (0.41) | CA2GPR84FFAR1EPHX2DNM1 | |
| SCHEMBL29180336 | 0.96 | CA2 (0.48) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL25319726 | 0.93 | LMNA (0.43) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL25317185 | 0.91 | S1PR2 (0.46) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL25698920 | 0.90 | CA2 (0.47) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL24764590 | 0.90 | CA2 (0.47) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL13003586 | 0.89 | CA2 (0.48) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL25317535 | 0.89 | CA2 (0.40) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL24340301 | 0.86 | CA2 (0.46) | CA2GRIK1GRIK2GPR84FFAR1 | |
| SCHEMBL20795803 | 0.86 | CA2 (0.46) | CA2GRIK1GRIK2GPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240410034-A1 | CYCLIC AMINE MONOAMIDES FOR EXTRACTING URANIUM(VI) AND PLUTONIUM(IV) AND FOR SEPARATING THEM WITHOUT REDUCING PLUTONIUM(IV) | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2024-12-12 | — | — | US | disclosed |
| CN-118354828-A | Cyclic amine monoamides for extracting uranium (VI) and plutonium (IV) and for separating them without reduction of the plutonium (IV) | 原子能与替代能源委员会 | 2024-07-16 | — | — | CN | disclosed |
| WO-2023067273-A1 | CYCLIC AMINE MONOAMIDES FOR THE EXTRACTION OF URANIUM(VI) AND PLUTONIUM(IV) AND FOR THE SEPARATION THEREOF WITHOUT REDUCTION OF THE PLUTONIUM(IV) | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2023-04-27 | — | — | WO | disclosed |
| US-11578031-B2 | Dissymmetric N,N-dialkylamides used particularly for separating uranium(VI) from plutonium(IV), synthesis thereof and uses of same | COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÊNERGIES ALTERNATIVES (FR) | 2023-02-14 | — | — | US | disclosed |
| US-20210332002-A1 | DISSYMMETRIC N,N-DIALKYLAMIDES USED PARTICULARLY FOR SEPARATING URANIUM(VI) FROM PLUTONIUM(IV), SYNTHESIS THEREOF AND USES OF SAME | ORANO CYCLE (FR) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240410034-A1 | CYCLIC AMINE MONOAMIDES FOR EXTRACTING URANIUM(VI) AND PLUTONIUM(IV) AND FOR SEPARATING THEM WITHOUT REDUCING PLUTONIUM(IV) | PADI2, PADI4, PADI1 | CA2 2313/4885GRIK1 2434/4885GRIK2 1845/4885 |
| US-11578031-B2 | Dissymmetric N,N-dialkylamides used particularly for separating uranium(VI) from plutonium(IV), synthesis thereof and uses of same | NOS2, NOS1, NOS3 | CA2 2594/4885GRIK1 3399/4885GRIK2 3359/4885 |
| US-20210332002-A1 | DISSYMMETRIC N,N-DIALKYLAMIDES USED PARTICULARLY FOR SEPARATING URANIUM(VI) FROM PLUTONIUM(IV), SYNTHESIS THEREOF AND USES OF SAME | NOS2, NOS1, NOS3 | CA2 2594/4885GRIK1 3399/4885GRIK2 3359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.